4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0000899243-20-018024
10% owner sold 250,000 shares at an average $23.97 ($5,993,052)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BRATTON DOUGLAS K 10% owner | 2020-06-26 | Sale | −108,473 | $23.84 | $2,586,441 | 589,562 | I |
| BRATTON DOUGLAS K 10% owner | 2020-06-26 | Sale | −13,604 | $24.67 | $335,637 | 575,958 | I |
| BRATTON DOUGLAS K 10% owner | 2020-06-29 | Sale | −61,807 | $23.84 | $1,473,399 | 514,151 | I |
| BRATTON DOUGLAS K 10% owner | 2020-06-29 | Sale | −20,771 | $24.50 | $508,975 | 493,380 | I |
| BRATTON DOUGLAS K 10% owner | 2020-06-30 | Sale | −45,145 | $24.01 | $1,083,733 | 448,235 | I |
| BRATTON DOUGLAS K 10% owner | 2020-06-30 | Sale | −200 | $24.34 | $4,868 | 448,035 | I |
| Open-market sales · 250,000 sh · avg $23.97 · $5,993,052 | |||||||
Loading xslF345X03/doc4.xml…